@article{TAU30423,
author = {Giovanni Motterle and R. Jeffrey Karnes},
title = {Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 5},
year = {2019},
keywords = {},
abstract = {In this study published in Urologic Oncology, Waingankar and the group form Mount Sinai (1) perform an analysis on the impact of pathological complete response to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC) on conditional surviving, meaning the updated probability of surviving after having survived each additional year after the treatment.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/30423}
}